Dimensional Fund Advisors’s RVL Pharmaceuticals plc Ordinary Shares RVLP Stock Holding History

Dimensional Fund Advisors’s Portfolio RVLP Stock Details RVLP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-55,095	Closed	-$30.9K	–	3524
2023 Q2	$30.9K	Sell	55,095 -17,569	-24%	-$15.5K	﹤0.01%	3434
2023 Q1	$82.9K	Sell	72,664 -23,487	-24%	-$28.2K	﹤0.01%	3327
2022 Q4	$108	Buy	96,151 +9,790	+11%	+$15.6K	﹤0.01%	3317
2022 Q3	$182K	Buy	86,361 +13,738	+19%	+$26.7K	﹤0.01%	3258
2022 Q2	$99K	Hold	72,623	–	–	﹤0.01%	3335
2022 Q1	$123K	Hold	72,623	–	–	﹤0.01%	3373
2021 Q4	$78K	Sell	72,623 -2,155	-3%	-$3.5K	﹤0.01%	3456
2021 Q3	$220K	Buy	74,778 +17,553	+31%	+$59K	﹤0.01%	3335
2021 Q2	$172K	Sell	57,225 -4,016	-7%	-$12.3K	﹤0.01%	3362
2021 Q1	$201K	Hold	61,241	–	–	﹤0.01%	3292
2020 Q4	$252K	Buy	61,241 +25,220	+70%	+$145K	﹤0.01%	3196
2020 Q3	$195K	Buy	36,021 +19,870	+123%	+$114K	﹤0.01%	3204
2020 Q2	$109K	Buy	+16,151	New	+$79K	﹤0.01%	3272

Other funds holding RVLP

ACM

Athyrium Capital Management New York $8.69M AUM 34.58% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Blackstone Inc New York $25.6B AUM 26.83% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

RJFSA

Raymond James Financial Services Advisors St. Petersburg, Florida $75.1B AUM 31.89% 1-Year Est. Return

TAM

Titleist Asset Management San Antonio, Texas $1.49B AUM 22.27% 1-Year Est. Return

Dimensional Fund Advisors's RVLP Position: Q3 2023 in Review

Dimensional Fund Advisors sold out of RVL Pharmaceuticals plc Ordinary Shares (RVLP) in Q3 2023, closing a stake of 55,095 shares — an estimated $30.9K sold.

Dimensional Fund Advisors first reported a position in RVLP in Q2 2020 and held it in 13 quarters. The position peaked at $252K in Q4 2020. 32 funds tracked by Wall St. Rank hold RVLP as of Q3 2023.

Dimensional Fund Advisors reported no remaining RVL Pharmaceuticals plc Ordinary Shares position as of Q3 2023 after selling out during the quarter.
Dimensional Fund Advisors sold 55,095 RVL Pharmaceuticals plc Ordinary Shares shares in Q3 2023, an estimated $30.9K.
Dimensional Fund Advisors first reported a position in RVL Pharmaceuticals plc Ordinary Shares in Q2 2020 and held it in 13 quarters.
Dimensional Fund Advisors's RVL Pharmaceuticals plc Ordinary Shares position peaked at $252K in Q4 2020.
32 funds tracked by Wall St. Rank held RVL Pharmaceuticals plc Ordinary Shares as of Q3 2023.

Based on Dimensional Fund Advisors's 13F filing for Q3 2023, filed 9 Nov 2023.